Cargando…

Retraction to the prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer

Detalles Bibliográficos
Autores principales:	Wang, Zhipeng, Liu, Haoyang, Zhao, Jinge, Chen, Junru, Zhu, Sha, Dai, Jindong, Ni, Yuchao, Xu, Nanwei, Zhao, Fengnian, He, Ben, Zhang, Xingming, Liang, Jiayu, Sun, Guangxi, Liu, Zhenhua, Shen, Pengfei, Zeng, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316107/ https://www.ncbi.nlm.nih.gov/pubmed/37404997 http://dx.doi.org/10.21037/atm-2023-7

Ejemplares similares

The prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer
por: Wang, Zhipeng, et al.
Publicado: (2023)

Plasma Exosomal AKR1C3 mRNA Expression Is a Predictive and Prognostic Biomarker in Patients with Metastatic Castration-Resistant Prostate Cancer
por: Zhu, Sha, et al.
Publicado: (2022)

Mutations in epigenetic regulator KMT2C detected by liquid biopsy are associated with worse survival in prostate cancer patients
por: ZHU, SHA, et al.
Publicado: (2023)

Exosomal TUBB3 mRNA expression of metastatic castration‐resistant prostate cancer patients: Association with patient outcome under abiraterone
por: Zhu, Sha, et al.
Publicado: (2021)

Comparison of Systemic Treatments for Metastatic Castration-Resistant Prostate Cancer After Docetaxel Failure: A Systematic Review and Network Meta-analysis
por: Chen, Junru, et al.
Publicado: (2022)

The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first‐line therapy for patients with metastatic castration‐resistant prostate cancer
por: Wang, Zhipeng, et al.
Publicado: (2021)

Efficacy and Safety of Individualized Schedule of Sunitinib by Drug Monitoring in Patients with Metastatic Renal Cell Carcinoma
por: Zhu, Xudong, et al.
Publicado: (2021)

Chronological Liquid Biopsy Reveals the Impact of Platinum-Based Chemotherapy on a Prostate Cancer Patient’s CDK12 Mutation: A Case Report
por: Zhu, Sha, et al.
Publicado: (2022)

The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis
por: Wang, Zhipeng, et al.
Publicado: (2020)

Survival Outcomes of Radical Prostatectomy + Extended Pelvic Lymph Node Dissection and Radiotherapy in Prostate Cancer Patients With a Risk of Lymph Node Invasion Over 5%: A Population-Based Analysis
por: Chen, Junru, et al.
Publicado: (2020)

Comparison of Current Systemic Combination Therapies for Metastatic Hormone-Sensitive Prostate Cancer and Selection of Candidates for Optimal Treatment: A Systematic Review and Bayesian Network Meta-Analysis
por: Chen, Junru, et al.
Publicado: (2020)

The Impact of Renal Impairment on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors
por: Zhang, Haoran, et al.
Publicado: (2020)

Homologous recombination deficiency (HRD) score in aggressive prostatic adenocarcinoma with or without intraductal carcinoma of the prostate (IDC-P)
por: Zhu, Sha, et al.
Publicado: (2022)

Integrated multi-omics analyses reveal that BCAM is associated with epigenetic modification and tumor microenvironment subtypes of clear cell renal cell carcinoma
por: Zhao, Junjie, et al.
Publicado: (2022)

The effect of additional chemotherapy on high-risk prostate cancer: a systematic review and meta-analysis
por: Chen, Junru, et al.
Publicado: (2018)

Dynamic multidisciplinary team discussions can improve the prognosis of metastatic castration‐resistant prostate cancer patients
por: Zhu, Sha, et al.
Publicado: (2021)

The value of transperineal apical prostate biopsy in predicting urethral/apical margin status after radical prostatectomy
por: Dai, Jindong, et al.
Publicado: (2019)

The Adiponectin-AdipoR1 Axis Mediates Tumor Progression and Tyrosine Kinase Inhibitor Resistance in Metastatic Renal Cell Carcinoma
por: Sun, Guangxi, et al.
Publicado: (2019)

MicroRNA-106a suppresses prostate cancer proliferation, migration and invasion by targeting tumor-derived IL-8
por: Shen, Pengfei, et al.
Publicado: (2020)

The prognostic implication of intraductal carcinoma of the prostate in metastatic castration-resistant prostate cancer and its potential predictive value in those treated with docetaxel or abiraterone as first-line therapy
por: Zhao, Jinge, et al.
Publicado: (2017)

Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database
por: Chen, Junru, et al.
Publicado: (2019)

Retraction: The prognostic potential and carcinogenesis of long non-coding RNA TUG1 in human cholangiocarcinoma
por: Xu, Yi, et al.
Publicado: (2023)

Multidisciplinary Team (MDT) Discussion Improves Overall Survival Outcomes for Metastatic Renal Cell Carcinoma Patients
por: Zeng, Yuhao, et al.
Publicado: (2023)

Retracted: Identification of Immune-Related Prognostic Markers in Gastric Cancer
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retraction: The prognostic value of prognostic nutritional index in hepatocellular carcinoma patients: A meta-analysis of observational studies
Publicado: (2022)

Retraction: Prognostic impact of prognostic nutritional index on renal cell carcinoma: A meta-analysis of 7,629 patients
Publicado: (2022)

Retracted: Regulatory Networks of Prognostic mRNAs in Pediatric Acute Myeloid Leukemia
por: Healthcare Engineering, Journal of
Publicado: (2022)

Retracted: Prognostic Evaluation of Vitrectomy Assisted by Lucentis in Diabetic Retinopathy and Neovascular Glaucoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retracted: An Immune-Related Prognostic Risk Model in Colon Cancer by Bioinformatics Analysis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retracted: Analysis of Prognostic Factors and Treatment Modes of Patients with Recurrent Endometrial Carcinoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retraction: Prognostic significance of DAPK promoter methylation in lymphoma: A meta-analysis
Publicado: (2023)

Retracted: Expression Profile and Prognostic Values of CDH Family Members in Lung Adenocarcinoma
por: Markers, Disease
Publicado: (2023)

Retracted: Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retracted: Risk Factors and Prognostic Analysis of Gastrointestinal Stromal Tumor Recurrence-Metastasis
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

iNOS is Associated with Tumorigenicity as an Independent Prognosticator in Human Intrahepatic Cholangiocarcinoma [Retraction]
Publicado: (2023)

The prognosis benefits of adjuvant versus salvage radiotherapy for patients after radical prostatectomy with adverse pathological features: a systematic review and meta-analysis
por: Tao, Ronggui, et al.
Publicado: (2019)

Retracted: Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retracted: Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Retracted: Characterization of the Immune Cell Infiltration Landscape and a New Prognostic Score in Glioblastoma
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retracted: Diagnostic and Prognostic Value of DACH1 Methylation in the Sensitivity of Esophageal Cancer to Radiotherapy
por: Imaging, Contrast Media & Molecular
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ippm30ai25cbcjbieae3hi4fa8